Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for Reducing Chronic Graft-Versus-Host Disease After Haploidentical Transplantation: Just Another Labor-Intensive Strategy, or Showing the Way?
- PMID: 27400943
- DOI: 10.1200/JCO.2016.67.7344
Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for Reducing Chronic Graft-Versus-Host Disease After Haploidentical Transplantation: Just Another Labor-Intensive Strategy, or Showing the Way?
Comment on
-
Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation.J Clin Oncol. 2016 Aug 20;34(24):2843-50. doi: 10.1200/JCO.2015.65.3642. Epub 2016 Jul 11. J Clin Oncol. 2016. PMID: 27400949 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources